Le Lézard
Classified in: Health
Subjects: HSP, BFA, LGB, FVT, DEI

La Clínica Del Pueblo a Hispanic Heritage Month Trailblazer for Health Equity


La Clínica Celebrates 40 Years of Inclusive Healthcare for Latinx Community

WASHINGTON, Sept. 13, 2023 /PRNewswire/ -- La Clínica del Pueblo (LCDP) commemorates four decades of providing high quality, vital healthcare to underserved Latino/Latinx communities in the Washington, D.C. area.

"La Clínica understands that all forms of discrimination affect health. That's why we go where the community is." 

LCDP began as a volunteer initiative in 1983 by Salvadoran immigrants in response to the urgent needs of immigrants affected by devastating conflicts. Today, LCDP has grown to a network of two Federally Qualified Health Center (FQHC) clinics, a school-based mental health program, and a thriving Community Health Center, annually serving 5,000+ individuals directly and 50,000+ through community outreach.

Following the 1991 Mount Pleasant riots, LCDP initiated cultural competency training for local agencies, and continues today in coalitions addressing social determinants of health, inclusion, and justice.

In 2010, LCDP opened the Empodérate Center, safe spaces for LGBTQ young adults addressing medical and societal roots of the HIV epidemic.

In 2015, they partnered with Prince Georges' County launching Mi Refugio, a youth mental health program serving 1,300+ students,100% graduating.

The pandemic disproportionately impacted marginalized communities. LCDP expanded services and collaborated with community partners breaking down barriers for communities of color.

In 2022, La Clínica increased its social impact efforts by providing:

"At the 40 year mark, we have accomplished so much, but still have work to do. I am certain that with the support of our partners and community, we will rise to meet the needs of new generations of immigrants. "

Catalina Sol, Executive Director

"La Clínica understands that all forms of discrimination affect health. That's why we don't just receive our clients in our clinics, we go where the community is."

Manuel Diaz-Ramirez, Community Health Action Director

Marking their 40th anniversary and National Hispanic Heritage Month, LCDP will host Fiesta Del Barrio, a grand-scale block party featuring Latinx music, food, art, and health activities. Come celebrate!

About La Clínica Del Pueblo

La Clínica is a 501c3 organization addressing the distinct health needs of Latinx immigrant communities through primary medical care, mental health services, and medical interpretation.  LCDP advocates for health equity for Latinx immigrants in the DMV. Visit www.lcdp.org.

SOURCE La Clínica del Pueblo


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: